These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 39128228)
1. FDX1 downregulation activates mitophagy and the PI3K/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production. Sun B; Ding P; Song Y; Zhou J; Chen X; Peng C; Liu S Redox Biol; 2024 Sep; 75():103302. PubMed ID: 39128228 [TBL] [Abstract][Full Text] [Related]
2. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis. Ma XL; Shen MN; Hu B; Wang BL; Yang WJ; Lv LH; Wang H; Zhou Y; Jin AL; Sun YF; Zhang CY; Qiu SJ; Pan BS; Zhou J; Fan J; Yang XR; Guo W J Hematol Oncol; 2019 Apr; 12(1):37. PubMed ID: 30971294 [TBL] [Abstract][Full Text] [Related]
3. Coptisine induces autophagic cell death through down-regulation of PI3K/Akt/mTOR signaling pathway and up-regulation of ROS-mediated mitochondrial dysfunction in hepatocellular carcinoma Hep3B cells. Kim SY; Hwangbo H; Kim MY; Ji SY; Lee H; Kim GY; Kwon CY; Leem SH; Hong SH; Cheong J; Choi YH Arch Biochem Biophys; 2021 Jan; 697():108688. PubMed ID: 33227289 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
5. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma. Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224 [TBL] [Abstract][Full Text] [Related]
6. NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells. Hu B; Ding GY; Fu PY; Zhu XD; Ji Y; Shi GM; Shen YH; Cai JB; Yang Z; Zhou J; Fan J; Sun HC; Kuang M; Huang C J Hematol Oncol; 2018 Feb; 11(1):28. PubMed ID: 29482578 [TBL] [Abstract][Full Text] [Related]
7. Piezoeletric cold atmospheric plasma induces apoptosis and autophagy in human hepatocellular carcinoma cells through blocking glycolysis and AKT/mTOR/HIF-1α pathway. Wang Y; Mang X; Li D; Chen Y; Cai Z; Tan F Free Radic Biol Med; 2023 Nov; 208():134-152. PubMed ID: 37543168 [TBL] [Abstract][Full Text] [Related]
8. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway. Zhang M; Liu S; Chua MS; Li H; Luo D; Wang S; Zhang S; Han B; Sun C Cell Death Dis; 2019 Aug; 10(8):612. PubMed ID: 31406106 [TBL] [Abstract][Full Text] [Related]
9. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway. Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274 [TBL] [Abstract][Full Text] [Related]
10. VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway. Zhangyuan G; Wang F; Zhang H; Jiang R; Tao X; Yu D; Jin K; Yu W; Liu Y; Yin Y; Shen J; Xu Q; Zhang W; Sun B Oncogene; 2020 Feb; 39(6):1213-1230. PubMed ID: 31605014 [TBL] [Abstract][Full Text] [Related]
11. DNA methylation-mediated silencing of Neuronatin promotes hepatocellular carcinoma proliferation through the PI3K-Akt signaling pathway. Deng Y; Lu L; Liang X; Li J; Zhu D; Huang H; Zhang Y; Zhang X; Chen Y; Liu X; Fu Y Life Sci; 2023 Jan; 312():121266. PubMed ID: 36473542 [TBL] [Abstract][Full Text] [Related]
12. microRNA-206 prevents hepatocellular carcinoma growth and metastasis via down-regulating CREB5 and inhibiting the PI3K/AKT signaling pathway. Chi Y; Gong Z; Xin H; Wang Z; Liu Z Cell Cycle; 2022 Dec; 21(24):2651-2663. PubMed ID: 36003063 [TBL] [Abstract][Full Text] [Related]
13. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target. Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213 [No Abstract] [Full Text] [Related]
14. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway. Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631 [TBL] [Abstract][Full Text] [Related]
15. HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway. Wang J; Yang K; Yang X; Jin T; Tian Y; Dai C; Xu F Mol Carcinog; 2024 Jul; 63(7):1275-1287. PubMed ID: 38578157 [TBL] [Abstract][Full Text] [Related]
16. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma. Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483 [TBL] [Abstract][Full Text] [Related]
17. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma. Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923 [TBL] [Abstract][Full Text] [Related]
18. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway. Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122 [TBL] [Abstract][Full Text] [Related]
19. AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway. Zhu G; Luo L; He Y; Xiao Y; Cai Z; Tong W; Deng W; Xie J; Zhong Y; Hu Z; Shan R Mol Carcinog; 2024 Sep; 63(9):1814-1826. PubMed ID: 38874176 [TBL] [Abstract][Full Text] [Related]
20. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]